Cite
The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
MLA
Savita Chaudhary, et al. “The Evaluation of Efficacy and Safety of Methotrexate and Pioglitazone in Psoriasis Patients: A Randomized, Open-Labeled, Active-Controlled Clinical Trial.” Indian Journal of Pharmacology, vol. 52, no. 1, Mar. 2020, pp. 16–22. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3ccb75335c7df680bb6dc47f2c7fe75e&authtype=sso&custid=ns315887.
APA
Savita Chaudhary, Ali Ahmad, Dilshad Ali Rizvi, Afroz Abidi, & Kshitij Saxena. (2020). The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial. Indian Journal of Pharmacology, 52(1), 16–22.
Chicago
Savita Chaudhary, Ali Ahmad, Dilshad Ali Rizvi, Afroz Abidi, and Kshitij Saxena. 2020. “The Evaluation of Efficacy and Safety of Methotrexate and Pioglitazone in Psoriasis Patients: A Randomized, Open-Labeled, Active-Controlled Clinical Trial.” Indian Journal of Pharmacology 52 (1): 16–22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3ccb75335c7df680bb6dc47f2c7fe75e&authtype=sso&custid=ns315887.